3:55-4:20

ARV Resistance: Epidemiologic Implications and Public Health Surveillance

 

Dr. Diane Bennett

 

World Health Organization

 

Geneva, Switzerland

4:20-4:45

Monitoring and Evaluation for ARV Programs in Resource-Poor Settings

 

Dr. Paul DeLay

 

UNAIDS

 

Geneva, Switzerland

4:45-5:10

The South African Plan for ARV Scale-up

 

Dr. Tony Mbewu,

 

Executive Director

 

Medical Research Council of South Africa

 

Capetown, South Africa

5:10-6:00

Discussion and Wrap-up



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement